PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit

Bleichmar Fonti & Auld LLP says a securities fraud class action has been filed against PROCEPT BioRobotics (NASDAQ:PRCT) and executives after an alleged discount program that incentivized bulk handpiece orders, potentially inflating revenue. The suit cites an 18% stock drop in Feb 2026 and earlier declines tied to Q2 2025, Q3 2025, and Q4 2025 results.

Procept BioRobotics reported Q2 2026 revenue up 19% year over year to $94.5 million, citing HYDROS system demand and record ASPs, while U.S. procedures grew 21% but missed expectations due to softness in legacy AQUABEAM accounts. Full-year 2026 revenue guidance remains $390 million to $410 million; U.S. procedures guidance lowered to 54,000–56,000. Management expects positive adjusted EBITDA in Q4 2026 and ongoing HYDROS replacement cycle through 2027.

The acquisition transforms Processa's pipeline with the addition of clinical-stage BTK inhibitor VT-7208, while a concurrent $200 million private placement is expected to fund development into 2029. Key Investor Takeaways Processa Pharmaceuticals (NASDAQ:PRCT) acquired Vidya Therapeutics, adding clinical-stage BTK inhibitor VT-7208 to its pipeline. The company simultaneously secured a private placement expected to raise approximately $200 million to fund multiple Phase 2 clinical programs.

PROCEPT BioRobotics (NASDAQ:PRCT) reported progress in its WATER IV prostate cancer program: enrollment completed for WATER IV RP (280 patients; Aquablation vs radical prostatectomy) with primary results expected at the AUA meeting in spring 2027, and FDA IDE approval for WATER IV AS (up to 333 patients; Aquablation vs active surveillance). Evercore ISI initiated coverage with an “Outperform” rating and $30 price target.

Woodside Energy and PEMEX signed an MoU to explore oil opportunities in Mexico's deep waters, expanding their partnership beyond the $7.2B Trion project, which is 64% complete and expected to produce 100,000 barrels/day by 2028. Woodside also increased production capacity in the U.S. Gulf with BP and made a discovery with Occidental and Chevron.

The U.S. Air Force's MH-139 Grey Wolf helicopter has reached Initial Operational Capability (IOC), according to the Air Force Global Strike Command. The Grey Wolf, which replaces the UH-1N Huey, offers improved speed, range, and payload, supporting missile-field security and ICBM convoy operations. The IOC coincides with the transition to the new Sentinel ICBM, which requires upgraded supporting infrastructure. Boeing received a $173 million contract for additional helicopters in 2025.